Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bjarne Robberstad

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
BMC Public Health|September 30, 2014
Maternal and perinatal mortality by place of delivery in sub-Saharan Africa: a meta-analysis of population-based cohort studiesJobiba Chinkhumba, Manuela De Allegri, Adamson S Muula, et al.
Malaria Journal|September 17, 2014
Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in TanzaniaAmani T Mori, Frida Ngalesoni, Ole F Norheim, et al.
JAMA Network Open|June 29, 2022
Appraising Drugs Based on Cost-effectiveness and Severity of Disease in Norwegian Drug Coverage DecisionsEirik Joakim Tranvåg, Øystein Ariansen Haaland, Bjarne Robberstad, et al.
Cost Effectiveness and Resource Allocation : C/E|May 8, 2015
Cost-effectiveness of live oral attenuated human rotavirus vaccine in TanzaniaGeorge M Ruhago, Frida N Ngalesoni, Bjarne Robberstad, et al.
Health Economics Review|August 18, 2020
Patient and health system costs of managing pregnancy and birth-related complications in sub-Saharan Africa: a systematic reviewAmani Thomas Mori, Peter Binyaruka, Peter Hangoma, et al.
BMJ Global Health|May 24, 2020
The cost-effectiveness of using results-based financing to reduce maternal and perinatal mortality in MalawiJobiba Chinkhumba, Manuela De Allegri, Stephan Brenner, et al.
BMC Pediatrics|July 22, 2018
Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years old in Malawi: a protocol for a cluster randomized trialThandile Gondwe, Bjarne Robberstad, Mavuto Mukaka, et al.
BMC Public Health|December 8, 2020
Is cycle network expansion cost-effective? A health economic evaluation of cycling in OsloAdmassu N Lamu, Abdulrahman Jbaily, Stéphane Verguet, et al.
BMC Health Services Research|December 21, 2018
Introducing post-discharge malaria chemoprevention (PMC) for management of severe anemia in Malawian children: a qualitative study of community health workers' perceptions and motivationThandile Nkosi-Gondwe, Bjarne Robberstad, Björn Blomberg, et al.
Vaccine|December 4, 2012
Response to "reply to: economic evaluation of second generation pneumococcal conjugate vaccines in Norway"Bjarne Robberstad, Per E Akselsen, Kari J Kværner, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
BMC Public Health|September 30, 2014
Maternal and perinatal mortality by place of delivery in sub-Saharan Africa: a meta-analysis of population-based cohort studiesJobiba Chinkhumba, Manuela De Allegri, Adamson S Muula, et al.
Malaria Journal|September 17, 2014
Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in TanzaniaAmani T Mori, Frida Ngalesoni, Ole F Norheim, et al.
JAMA Network Open|June 29, 2022
Appraising Drugs Based on Cost-effectiveness and Severity of Disease in Norwegian Drug Coverage DecisionsEirik Joakim Tranvåg, Øystein Ariansen Haaland, Bjarne Robberstad, et al.
Cost Effectiveness and Resource Allocation : C/E|May 8, 2015
Cost-effectiveness of live oral attenuated human rotavirus vaccine in TanzaniaGeorge M Ruhago, Frida N Ngalesoni, Bjarne Robberstad, et al.
Health Economics Review|August 18, 2020
Patient and health system costs of managing pregnancy and birth-related complications in sub-Saharan Africa: a systematic reviewAmani Thomas Mori, Peter Binyaruka, Peter Hangoma, et al.
BMJ Global Health|May 24, 2020
The cost-effectiveness of using results-based financing to reduce maternal and perinatal mortality in MalawiJobiba Chinkhumba, Manuela De Allegri, Stephan Brenner, et al.
BMC Pediatrics|July 22, 2018
Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years old in Malawi: a protocol for a cluster randomized trialThandile Gondwe, Bjarne Robberstad, Mavuto Mukaka, et al.
BMC Public Health|December 8, 2020
Is cycle network expansion cost-effective? A health economic evaluation of cycling in OsloAdmassu N Lamu, Abdulrahman Jbaily, Stéphane Verguet, et al.
BMC Health Services Research|December 21, 2018
Introducing post-discharge malaria chemoprevention (PMC) for management of severe anemia in Malawian children: a qualitative study of community health workers' perceptions and motivationThandile Nkosi-Gondwe, Bjarne Robberstad, Björn Blomberg, et al.
Vaccine|December 4, 2012
Response to "reply to: economic evaluation of second generation pneumococcal conjugate vaccines in Norway"Bjarne Robberstad, Per E Akselsen, Kari J Kværner, et al.
Pageof 10